CIK 0000885590
- Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- Phone
- +1 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $258,894
- in 1 filing, $259K under 10b5-1 plans
Net −$258,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-07-11 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Sale | −3,968 | $24.81 | $98K | 61,722 |
| 2019-06-28 | WECHSLER AMY B Director | Grant or award | +1,263 | $25.22 | $32K | 86,351 |
| 2019-06-28 | ROBERTSON RUSSEL C Director | Grant or award | +1,486 | $25.22 | $37K | 91,014 |
| 2019-06-28 | Paulson John Director | Grant or award | +1,090 | $25.22 | $27K | 53,535 |
| 2019-06-28 | DE SCHUTTER RICHARD U Director | Grant or award | +1,239 | $25.22 | $31K | 271,776 |
| 2019-06-24 | McKenna Mark C. President, Salix | Shares withheld for taxes | −1,913 | $23.82 | $46K | 31,529 |
| 2019-06-13 | ValueAct Holdings, L.P. Director | Other disposition | −111,440 | 948,353 | ||
| 2019-06-04 | Eldessouky Sam SVP, CHIEF ACCOUNTING OFFICER | Shares withheld for taxes | −6,370 | $20.73 | $132K | 61,444 |
Page 31 of 31 · 608 trades